


Early Data on Novel MK2 Inhibitor to Treat Inflammatory Diseases Promising

Medication Preferences & Current Practices for PsA

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

Pre-Eclampsia Risk & Rheumatic Disease

Improving Bone Mineral Density: Risedronate vs. Denosumab

Research Roundup: Abstract Data Presented at ACR Convergence 2021

Clinical Insights into Gout Management: Q&A with Dr. Tuhina Neogi
Diet & Gout Research Presented at ACR Convergence 2021

Highlights from ACR Convergence’s Late-Breaking Abstracts
- 1
- 2
- 3
- …
- 16
- Next Page »